Literature DB >> 3953659

Effects of nucleotides on expression of the folate sensitive fragile sites.

G R Sutherland, E Baker.   

Abstract

Further studies on the effect of nucleotides upon expression of the folate sensitive fragile sites have confirmed that high concentrations of thymidine (300 mg/l) but not BrdU (600 mg/l) induce these fragile sites. Induction by thymidine can be suppressed by addition of cytidine in a dose response manner. Studies on other nucleotides suggest that guanosine, but not adenosine or cytidine, can induce the fragile sites. The previously hypothesised model for the DNA at a fragile site as a naturally occurring polypurine/polypyrimidine sequence which becomes amplified is further developed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3953659     DOI: 10.1002/ajmg.1320230133

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Uridine enhances expression of the fragile X chromosome in human lymphocytes.

Authors:  M Kähkönen; R Haataja; J Leisti
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

2.  Cytological evidence of defective template in the fragile X chromosome.

Authors:  B Kerem; R Goitein; T Schaap
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

3.  The role of recombination in the evolvement of the fragile X mutation.

Authors:  T Schaap
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

4.  Study of human chromosome V. The effects of thymidine concentration and timing on the expression of uridine-induced constitutive fragile sites.

Authors:  S J Lin; C Figueiredo; L J Sciorra; M L Lee
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

5.  Synergistic effect of hydroxyurea and excessive thymidine on the expression of the common fragile sites at 3p14 and 16q23.

Authors:  Z A Yan; X Z Li; X T Zhou
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

6.  Fragile X expression and X inactivation. I. The expression of the fragile site at Xq27.3 is not suppressed on inactive X chromosomes separated from the active homologue.

Authors:  D Wöhrle; J P Fryns; P Steinbach
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

7.  Fragile X expression and X inactivation. II. The fragile site at Xq27.3 has a basic function in the pathogenesis of fragile X-linked mental retardation.

Authors:  D Wöhrle; P Steinbach
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

Review 8.  The fragile X syndrome: isolation of the FMR-1 gene and characterization of the fragile X mutation.

Authors:  B A Oostra; A J Verkerk
Journal:  Chromosoma       Date:  1992-04       Impact factor: 4.316

9.  Physical map of human Xq27-qter: localizing the region of the fragile X mutation.

Authors:  A Poustka; A Dietrich; G Langenstein; D Toniolo; S T Warren; H Lehrach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Differential expression of the ICF (immunodeficiency, centromeric heterochromatin, facial anomalies) mutation in lymphocytes and fibroblasts.

Authors:  P Maraschio; R Tupler; E Dainotti; M Piantanida; G Cazzola; L Tiepolo
Journal:  J Med Genet       Date:  1989-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.